| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Sep―17 |
Choline-Retinoic Acid Ionic Liquid [Cho][Ra] as Potential Adjuvant to Enhance Humoral, Cellular, and Mucosal Immune Responses of SARS-CoV-2 RBD Antigen |
Hongyu Zhu, Sen Yang, Jingyang Zhao, Liuyang Wang, Chenghao Gao, Yanan Sheng, Xuan Lin, Zhiguo Su, Kiichi Sato, Zhongyu Hu, Songping Zhang |
| 2 |
[GO] |
2025―Jul―24 |
Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies |
Inji Jung, Dinesh Kumar Sriramulu, Jeong Hyeon Yoon, Jisun Lee, Tae Woo Kim, Dae-Hyuk Kweon, Sun-Gu Lee, Sang Taek Jung |
| 3 |
[GO] |
2024―Jul―26 |
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs |
Jisun Lee, Bomi Kim, Hye-Min Woo, Jun-Won Kim, Inji Jung, Seong-Wook Park, Yong-Sung Kim, Jung-Hyun Na, Sang Taek Jung |
| 4 |
[GO] |
2024―Jun―26 |
Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants |
Lei He, Qian Wu, Zhaoyong Zhang, Lingling Chen, Kuai Yu, Leibin Li, Qiong Jia, Yanqun Wang, Jianqiang Ni, Chuanbin Wang, Qi Li, Xinyan Zhai, Jincun Zhao, Yuliang Liu, Ruiwen Fan, Yi-Ping Li |
| 5 |
[GO] |
2024―Jan―30 |
SARS-CoV-2 NSP2 as a Potential Delivery Vehicle for Proteins |
Ningze Zheng, Shurui Liu, Jianheng Chen, Yue Xu, Wenyin Cao, Jinyi Lin, Guang Lu, Guigen Zhang |
| 6 |
[GO] |
2023―Nov―09 |
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs: A Comprehensive Bioinformatics Study with Generative Adversarial Network-Based Peptide Design and In Vitro Assays |
Ricardo D. González, Susana Simões, Lino Ferreira, Alexandra T. P. Carvalho |
| 7 |
[GO] |
2023―Sep―12 |
Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization |
Ji Wang, Yanhao Zhang, Chao Liu, Wenhui Zha, Shuo Dong, Yang Wang, Yuhao Jiang, Hanlei Xing, Xinsong Li |
| 8 |
[GO] |
2023―Mar―23 |
Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine |
Rasmus Münter, Erik Sørensen, Rasmus B. Hasselbalch, Esben Christensen, Susanne D. Nielsen, Peter Garred, Sisse R. Ostrowski, Henning Bundgaard, Kasper K. Iversen, Thomas L. Andresen, Jannik B. Larsen |
| 9 |
[GO] |
2023―Jan―20 |
Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131I-Labeling and SPECT Imaging |
Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, Xiang Li, Wenhui Ma, Fei Kang, Mingru Zhang, Jing Wang |
| 10 |
[GO] |
2022―Nov―30 |
Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections |
Daiqin Chen, Xin Yun, Daiheon Lee, Joseph R. DiCostanzo, Oreola Donini, Cecilia M. Shikuma, Karen Thompson, Axel T. Lehrer, Larissa Shimoda, Jung Soo Suk |
| 11 |
[GO] |
2022―Sep―06 |
A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections |
Jianzhong Xian, Hongbin Huang, Guolong Huang, Renwei Zhou, Min Yang, Yifan Qiu, Lei Bi, Zhongzhen Su, Fei Xiao, Hong Shan, Hongjun Jin |
| 12 |
[GO] |
2021―Dec―06 |
Voices in Molecular Pharmaceutics: Meet Dr. Venecia Wilson, a Scientist Helping to Maintain a Robust Supply Chain for the Manufacture of COVID-19 Vaccines |
Venecia R. Wilson |
| 13 |
[GO] |
2021―May―13 |
The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine |
Elisabetta Vulpis, Francesca Giulimondi, Luca Digiacomo, Alessandra Zingoni, Reihaneh Safavi-Sohi, Shahriar Sharifi, Giulio Caracciolo, Morteza Mahmoudi |
| 14 |
[GO] |
2021―May―04 |
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses |
Muhammad Imran Sajid, Muhammad Moazzam, Yeseom Cho, Shun Kato, Ava Xu, J. J. Way, Sandeep Lohan, Rakesh K. Tiwari |
| 15 |
[GO] |
2021―Jan―19 |
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies |
Vrishali S. Salian, Jessica A. Wright, Peter T. Vedell, Sanjana Nair, Chenxu Li, Mahathi Kandimalla, Xiaojia Tang, Eva M. Carmona Porquera, Krishna R. Kalari, Karunya K. Kandimalla |
| 16 |
[GO] |
2020―May―07 |
Emerging Biomolecular Testing to Assess Risk of Mortality from COVID-19 Infection |
Morteza Mahmoudi |
|
